Who Paid My Doc
Carmen Flores
Surgical Critical Care Las Vegas, NV Medical Doctor
NPI 1174966576 CMS profile 5704272
1524 Pinto Ln Fl 2, Las Vegas, NV 89106
General payments
$102,969
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Carmen Flores of Las Vegas, NV is reported in the CMS Open Payments database as having received $102,969 across 203 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 98th percentile of Surgical Critical Care profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $16,602 | 39 | |
| 2024 | General | $33,415 | 82 | |
| 2023 | General | $37,637 | 35 | |
| 2022 | General | $4,774 | 15 | |
| 2021 | General | $9,707 | 24 | |
| 2019 | General | $834 | 8 |
Beside peers
- Carmen Flores
- Surgical Critical Care median
- Middle half of Surgical Critical Care
- National median
In program year 2025, general payments to Carmen Flores were reported at $16,602. Among 1,068 Surgical Critical Care profiles paid that year, the median was $231 and the middle half received between $82 and $1,489.
Show as a table
| Year | Carmen Flores | Surgical Critical Care median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $834 | $161 | $57–$631 | $163 |
| 2020 | $0 | $116 | $33–$383 | $114 |
| 2021 | $9,707 | $121 | $37–$475 | $132 |
| 2022 | $4,774 | $163 | $53–$789 | $149 |
| 2023 | $37,637 | $188 | $67–$1,031 | $160 |
| 2024 | $33,415 | $216 | $80–$1,133 | $164 |
| 2025 | $16,602 | $231 | $82–$1,489 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 14 billing codesPaid by Medicare
$4,734
Medicare patients
13
Services billed
41
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Cancer | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
203 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Surgical Critical Care in Nevada
Casey Thomas
Surgical Critical Care · Las Vegas, NV
Jocelyn Burke
Surgical Critical Care · Las Vegas, NV
Manrique Guerrero
Surgical Critical Care · Las Vegas, NV
John Bruun
Surgical Critical Care · Nellis Afb, NV
Laura Crankshaw
Surgical Critical Care · Las Vegas, NV
Kitae Kim
Surgical Critical Care · Las Vegas, NV
Related records
Surgical Critical Care in Nevada
Practitioners in the same specialty and state, ranked by reported value.
All Surgical Critical Care
Everyone recorded under this specialty, nationwide.
Doctors in Nevada
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.